December 7, 2022
Psychiatry Advisor highlighted recent University of Cincinnati research that found in utero exposure to certain flame retardant chemicals may be a risk factor for developing anxiety symptoms in early adolescence.
December 6, 2022
Forbes highlighted research from the University of Cincinnati's Jeffrey Mills and Jeffrey Strawn examining factors behind the decision to begin or decline medication treatment for childhood anxiety disorders after cognitive behavioral therapy did not lead to improvement.
January 12, 2024
University of Cincinnati research on how eating strawberries can reduce dementia risk was featured in a "LIVE with Kelly and Mark" segment on superfoods to eat in 2024.
December 21, 2023
U.S. News & World Report highlighted research led by the University of Cincinnati's Francisco Romo-Nava that found spinal cord stimulation was well tolerated and has therapeutic potential to treat depression.
May 23, 2024
Interesting Engineering and Drug Target Review highlighted research led by University of Cincinnati and Cincinnati Children's Hospital researcher Ziyuan Guo that developed the first human mini-brain that incorporates a fully functional blood-brain barrier.
May 3, 2024
The University of Cincinnati's Robert Cohen spoke with Local 12 about the GRADE study that shows how a new medication needs to be developed to help treat people with type two diabetes.
July 15, 2024
WVXU highlighted research led by the University of Cincinnati's Lesley Arnold and Swing Therapeutics that found a self-guided smartphone-based behavioral therapy led to significant improvements for patients with fibromyalgia.
June 28, 2024
WVXU and the Cincinnati Business Courier highlighted a new collaboration between the University of Cincinnati College of Medicine, UC Health GE HealthCare, JobsOhio, REDI Cincinnati and Cincinnati Children’s to create an MRI Research and Development Center of Excellence located on UC’s medical campus.
December 10, 2020
Dustin Calhoun, MD, of the Department of Emergency Medicine in the UC College of Medicine, was interviewed by the Wall Street Journal about how the rollout of COVID-19 vaccines would work.
October 12, 2020
In one of the first studies of its kind, a University of Cincinnati researcher is using a grant from the Ohio attorney general’s office to research the pharmacogenomics of opioid addiction. The grant was awarded to Caroline Freiermuth, MD, associate professor in the Department of Emergency Medicine at the UC College of Medicine, the principal investigator for the study. The initial year will be supported with $1.63 million from the attorney general’s office, secured through money collected from pharmaceutical companies involved in opioid lawsuits.